Navigation Links
CompuCyte Corporation and Program in Cellular and Molecular Medicine at Children's Hospital Boston Announce Joint Program for Quantitative Imaging Cytometry Research Services
Date:3/10/2009

BOSTON, March 10 /PRNewswire/ -- CompuCyte Corporation and the Program in Cellular and Molecular Medicine at Children's Hospital Boston (also known as the Immune Disease Institute) today announced the establishment of a joint Quantitative Imaging Cytometry program. The Program in Cellular and Molecular Medicine is an affiliate of Harvard Medical School (HMS) and is located in the Longwood Medical Area. Under the terms of the agreement, CompuCyte will make its proprietary laser scanning cytometry instrumentation and technical support programs available to trained personnel, and will provide quantitative imaging cytometry and analysis services to the larger Longwood Medical Area community.

"The joint program with CompuCyte gives our facility a new and powerful asset to offer the HMS research community. CompuCyte's instrumentation provides the ability to combine the quantitative data traditionally generated through flow cytometry with laser-scanned images of cells and tissues, without the traditional flow requirement for harsh sample-processing and the unwanted disturbance of native cells and tissue architecture normally associated with traditional cytometry," explained Dr. Natasha Barteneva, Director of the Flow and Imaging Cytometry Resource of the Program in Cellular and Molecular Medicine and manager of the joint program. "The agreement with CompuCyte expands our capacity in quantitative imaging cytometry and reinforces our commitment to providing our researchers access to the most advanced analytical technologies," stated Dr. Margaret Bradley, Chief Scientific Administrative Officer.

"Laser Scanning Cytometry (LSC) technology has become a gold standard in quantitative automated analysis of intact adherent cells, tissue specimens, tissue microarrays and small cellular samples, such as small needle aspirates," explained Dr. Elena Holden, CompuCyte's President and Chief Executive Officer. "The reputation of the Program in Cellular and Molecular Medicine for quality and scientific vigor is well known. We are enthusiastic about the opportunity to collaborate with their Flow and Imaging Cytometry Resource and to add our proprietary LSC technology to their existing infrastructure."

The Program in Cellular and Molecular Medicine at Children's Hospital Boston (also known as the Immune Disease Institute) is a non-profit research institution academically affiliated with Harvard Medical School, recognized worldwide for its discoveries that increase the body's ability to fight disease. Its mission is fundamental biomedical research to improve human health, harness inflammation, and strengthen immune defense.

CompuCyte Corporation, a private company headquartered in Westwood, Massachusetts, is a pioneer and leader in the development of quantitative imaging cytometry instrumentation based on patented laser scanning cytometry technology. The company's iCyte(R), iCys(R), and iColor(R) cytometers enable true quantitative cytometric image analysis of cellular and tissue specimens in life science research, drug safety, toxicology studies, biomarker discovery and clinical trials.


'/>"/>
SOURCE CompuCyte Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Brooke Franchise Corporation Announces Selected July Results
3. MedThink Communications Retained by NanoBio Corporation
4. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
5. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
6. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
7. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
8. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
9. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
10. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
11. AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... Serenity Recovery, ... another video highlighting one of the many supplemental program options offered at their ... a 5 th Degree Black Belt in the Shorin-ryu style of Karate that ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Horizon Foundation for ... pilot initiative to improve oral health-related awareness, education, prevention and treatment for young ... providers and promote best practices in 10 New Jersey counties where dental health ...
(Date:5/25/2016)... ... 2016 , ... New studies published today by the ... states. The outcomes examined in these studies include recovery of physical health and ... medical care. , “The goal of the studies is to provide information about ...
(Date:5/25/2016)... ... May 25, 2016 , ... Cheryl Bowker of Bowker ... bestow: the Dick McKenna Good Hands Legacy Award. McKenna ran one of Allstate’s most ... continues to inspire all those who knew him. The award named for him is ...
(Date:5/25/2016)... ... ... Casa Velas, an adults-only boutique hotel in Puerto Vallarta, Mexico, introduces a ... wellness suites . The two 1,350 sq. ft. suites which debuted in late 2015 ... amenities, from a custom soap selection and in-suite exercise kit to a personal wellness ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... May 23, 2016 According ... Share, Development, Growth and Demand Forecast to 2022 ... Other), by Application (Drug Discovery and Development, Proteomics, ... (Pharmaceuticals, Life Science and Biotechnology, Academic and Research ... Research, the global mass spectrometry market ...
(Date:5/23/2016)... -- The World Health Organization (WHO) expanded the Intended Use ... aged 13 years, and above. Effective immediately, the PrePex device, ... adolescent males in the 14 priority countries in Southern and ... male circumcision device to receive WHO Prequalification on 31 May ... said: " The expanded use of PrePex for ...
(Date:5/23/2016)... UAE, May 23, 2016 Experts ... of Precision Medicine and the role of technology ...   The First International Conference of VPS-Penn Medicine ... distinguished patronage and presence of Sheikh Nahyan bin Mubarak Al ... in Precision Medicine, which helps provide personalized medicine and tailor-made ...
Breaking Medicine Technology: